CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
about
The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensisQuest for correlates of protection against tuberculosisThe production of alpha/beta and gamma/delta double negative (DN) T-cells and their role in the maintenance of pregnancyImmunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS)Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infectionsClonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method.The composition of T-cell subsets are altered in the burn wound early after injury.Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.The clinical correlation of regulatory T cells and cyclic adenosine monophosphate in enterovirus 71 infection.Human CD4- 8- T cells are a distinctive immunoregulatory subset.Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade.Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.MHC class II restricted innate-like double negative T cells contribute to optimal primary and secondary immunity to Leishmania majorHost-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicityCellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVSThe contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants.Non-FcεR bearing mast cells secrete sufficient interleukin-4 to control Francisella tularensis replication within macrophagesDouble negative regulatory T cells in transplantation and autoimmunity: recent progress and future directionsA defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infectionMouse model for sublethal Leptospira interrogans infection.Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer.Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.Contribution of Thy1+ NK cells to protective IFN-γ production during Salmonella typhimurium infectionsListeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infectionDefining the immune response to Ehrlichia species using murine models.Induction of Unconventional T Cells by a Mutant Mycobacterium bovis BCG Strain Formulated in Cationic Liposomes Correlates with Protection against Mycobacterium tuberculosis Infections of Immunocompromised Mice.MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection.T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteriaDevelopment of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosisIdentification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensisHumoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.Vaccination with an attenuated strain of Francisella novicida prevents T-cell depletion and protects mice infected with the wild-type strain from severe sepsis
P2860
Q27324829-34808804-B29C-4B06-91F1-69CFB9350BFCQ28084282-320AF81F-AF50-4866-AAFF-904148E71A92Q28087072-0716AAE0-3B8B-4735-9DC4-A1634500FC19Q28748210-F4ADFD12-C771-45D7-95EC-C73ABBD4C847Q30371742-C6A92802-B8A4-4D77-BCAC-B838A037B7AFQ33693895-029EFE51-2088-4071-9675-415BE93421DAQ33721633-74BCBB26-626A-4651-9130-7706682A4E0FQ33757847-0FD43F11-53C3-46BA-A3A6-4A73015AA46AQ33788322-32F9BBA0-DA4F-4673-B501-61CB040B7116Q33882741-9138793B-F8BD-427A-8C38-514A3C1D4559Q33919504-29A0D18A-39A2-4BD9-9144-5F40EBC07BF6Q34079316-2E25DC90-C3AF-4584-B294-5CAEFBD27CF7Q34139968-6CE88118-9141-47AB-88FB-D3190EC09BFBQ34215441-DD1186D5-7AF1-4DC6-9735-990675B13FA8Q34237666-83FC42A8-6B07-46C1-8B10-7A943B7A2763Q34423341-3FCDE073-5367-4CA7-8B8F-17FE5F29B1D8Q34601931-9C2CC8E9-4F5D-466C-BE71-7ACBCCF9F545Q35009750-60D1A3A2-049A-4919-9944-7804FABA5971Q35163979-B6165621-44B4-44A3-A3D6-BA8BF4DB0FE6Q35716736-584A3A75-9BD7-4A2D-9126-0C5DAEB68D6AQ35784088-034EACDA-5BCD-495B-BECE-EE0AFD6D4745Q35808608-303386A2-609C-4526-89CD-FE34AA61A0C6Q36163097-575D7667-2082-4795-9CB8-C4F4E3E4DDFFQ36281338-EDACDD23-F077-424A-A859-37454CDA182BQ36421591-A797711B-487A-40A0-81F5-668F7BB10DE6Q36557519-78C28862-8469-4E95-8C8C-1477DFF4845DQ36558802-92D3A11B-AFE3-49BD-8C1D-1F97BEF4C321Q36598235-F93B3D54-464F-4345-A2B3-063EB2E387D9Q36600365-2BD5D49D-25A1-477B-8CD4-ED38F6014264Q36710729-45928219-4D59-427D-AA85-51781F575325Q36775410-7B715448-0581-4F5D-8956-095FBD456322Q37029697-DBCF9EE7-9256-44EE-8051-F30D3243205AQ37067294-392AA433-254C-4AAA-94CF-B6AB49C73061Q37104082-34A6465A-344E-44A2-B188-4E222B494E07Q37191318-A973575D-5D17-4F6E-8DE4-DBA79FEB5699Q37256107-4F50BF42-FA8A-4A01-82E3-B5E73990DE97Q37258244-4CB7FC92-6EEF-48A0-8EC7-923684402EF3Q37275515-C184AF17-8D57-4671-ABCD-FAA6DF8430B6Q37287818-034C7273-8F57-4F9B-8577-B697E5F4631FQ37355859-19D39726-EBEB-4255-9035-377314B8D63D
P2860
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
@ast
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
@en
type
label
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
@ast
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
@en
prefLabel
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
@ast
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
@en
P2093
P2860
P356
P1476
CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
@en
P2093
Elizabeth Hamilton
James Forman
Jeffrey A Frelinger
Karen L Elkins
Siobhán C Cowley
P2860
P304
P356
10.1084/JEM.20050569
P407
P577
2005-07-01T00:00:00Z